J.F. Colombel

474 total citations
18 papers, 368 citations indexed

About

J.F. Colombel is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, J.F. Colombel has authored 18 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in J.F. Colombel's work include Inflammatory Bowel Disease (11 papers), Eosinophilic Esophagitis (5 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). J.F. Colombel is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Eosinophilic Esophagitis (5 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). J.F. Colombel collaborates with scholars based in France, Germany and United Kingdom. J.F. Colombel's co-authors include J Paris, Antoine Cortot, B. Wallaert, C Voisin, A B Tonnel, MF Neurath, Angela Watson, P Bonnière, X. Marchandise and Yvon Riou and has published in prestigious journals such as Gut, CHEST Journal and The American Journal of Gastroenterology.

In The Last Decade

J.F. Colombel

16 papers receiving 354 citations

Peers

J.F. Colombel

GENET

EPIDE

SURGE

PHYSI

PRM

Ella M. van den Berg‐Loonen Netherlands

J Freeman United Kingdom

Luís Antunes Portugal

Hiroki Sonoyama Japan

Gunnar Olsson Sweden

David M. Sander Germany

Christer Åhrén Sweden

Mari Hayashida Japan

Masahiro Iwabuchi Japan

Natalie Funakoshi France

Ella M. van den Berg‐Loonen Netherlands

J.F. Colombel

159 ×1.2

GENET

77 ×0.6

EPIDE

230 ×1.9

SURGE

62 ×0.7

PHYSI

79 ×0.9

PRM

Citations per year, relative to J.F. Colombel J.F. Colombel (= 1×) peers Ella M. van den Berg‐Loonen

Countries citing papers authored by J.F. Colombel

Since Specialization

Citations

This map shows the geographic impact of J.F. Colombel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.F. Colombel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.F. Colombel more than expected).

Fields of papers citing papers by J.F. Colombel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.F. Colombel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.F. Colombel. The network helps show where J.F. Colombel may publish in the future.

Co-authorship network of co-authors of J.F. Colombel

This figure shows the co-authorship network connecting the top 25 collaborators of J.F. Colombel. A scholar is included among the top collaborators of J.F. Colombel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.F. Colombel. J.F. Colombel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Gibson, Peter G., Colleen Marano, Richard Strauss, et al.. (2013). P142 Subcutaneously administered golimumab induction therapy improves health states measured by EQ-5D in patients with moderately to severely active ulcerative colitis: results from PURSUIT-SC. Journal of Crohn s and Colitis. 7. S65–S65. 2 indexed citations

Kamm, MA, Stephen B. Hanauer, Remo Panaccione, et al.. (2009). P083 - Steroid-free remission in patients with Crohn's disease who received adalimumab therapy for at least 3 years: long-term results from CHARM. Journal of Crohn s and Colitis. 3(1). S43–S44. 1 indexed citations

Sandborn, William J., Séverine Vermeire, Geert D’Haens, et al.. (2009). 13 - WELCOME: A randomized, double-blind, controlled trial comparing certolizumab pegol 400mg every 2 weeks with every 4 weeks for maintenance of response and remission in patients with moderate-to-severe Crohn's disease with secondary failure to infliximab. Journal of Crohn s and Colitis. 3(1). S8–S9.

Beaugerie, Laurent, J.F. Colombel, Xavier Hébuterne, et al.. (2009). P149 - Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME study. Journal of Crohn s and Colitis. 3(1). S70–S70. 1 indexed citations

Colombel, J.F., et al.. (2008). Impact of long-term Adalimumab treatment on fistula healing in patients with moderate to severe Crohnʼs Disease. Inflammatory Bowel Diseases. 14. S32–S32. 1 indexed citations

Rutgeerts, Paul, Brian G. Feagan, Walter Reinisch, et al.. (2008). Infliximab reduces colectomy in patients with moderate-to-severe ulcerative colitis: colectomy analysis from ACT 1 and ACT 2. Inflammatory Bowel Diseases. 14. S2–S2. 3 indexed citations

Colombel, J.F., Angela Watson, & MF Neurath. (2007). The 10 remaining mysteries of inflammatory bowel disease. Gut. 57(4). 429–433. 50 indexed citations

Colombel, J.F., M A Kamm, David J. Schwartz, et al.. (2007). Sustainability of Adalimumab in Fistula Healing and Response: 2-Year Data from CHARM and 12-Month Open-Label Extension Follow-Up Study. The American Journal of Gastroenterology. 102. S497–S498. 5 indexed citations

Bardin, Nathalie, Dominique Reumaux, K. Geboes, et al.. (2005). Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflammatory Bowel Diseases. 12(1). 16–21. 64 indexed citations

10.

Lebuffe, Gilles, Élie Haddad, Pierre Desreumaux, et al.. (2000). Impaired contractile response of mesenteric arteries in Crohn’s disease. Alimentary Pharmacology & Therapeutics. 14(10). 1279–1285. 6 indexed citations

11.

Brandt, Eric B., Heide Müller‐Alouf, Pierre Desreumaux, et al.. (1998). Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease.. PubMed. 9(4). 647–53. 15 indexed citations

12.

Lecomte-Houcke, M, et al.. (1998). [Eosinophilic pancreatitis: a difficult diagnosis].. PubMed. 22(11). 970–2. 2 indexed citations

13.

Boruchowicz, Arnaud, et al.. (1995). Idiopathic acute pancreatitis and sarcoidosis.. PubMed. 19(4). 439–41. 8 indexed citations

14.

Nakad, A., J.F. Colombel, André Geubel, et al.. (1990). [Is jaundice a cause of error in the interpretation of CA 19-9 blood levels?].. PubMed. 52(1-2). 17–22.

15.

Colombel, J.F., Martin Parent, Antoine Cortot, et al.. (1989). Paraneoplastic intestinal pseudo-obstruction as the presenting feature of small cell lung cancer. Lung Cancer. 5(4). 26–26. 6 indexed citations

16.

Bonnière, P, B. Wallaert, Antoine Cortot, et al.. (1986). Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.. Gut. 27(8). 919–925. 119 indexed citations

17.

Wallaert, B., J.F. Colombel, A B Tonnel, et al.. (1985). Evidence of Lymphocyte Alveolitis in Crohn's Disease. CHEST Journal. 87(3). 363–367. 82 indexed citations

18.

Colombel, J.F., et al.. (1984). [Gastric metastasis of a malignant melanoma of the choroid].. PubMed. 8(10). 754–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact